190 related articles for article (PubMed ID: 26059097)
1. Tryptophan derivatives regulate the transcription of Oct4 in stem-like cancer cells.
Cheng J; Li W; Kang B; Zhou Y; Song J; Dan S; Yang Y; Zhang X; Li J; Yin S; Cao H; Yao H; Zhu C; Yi W; Zhao Q; Xu X; Zheng M; Zheng S; Li L; Shen B; Wang YJ
Nat Commun; 2015 Jun; 6():7209. PubMed ID: 26059097
[TBL] [Abstract][Full Text] [Related]
2. Alu retrotransposons promote differentiation of human carcinoma cells through the aryl hydrocarbon receptor.
Morales-Hernández A; González-Rico FJ; Román AC; Rico-Leo E; Alvarez-Barrientos A; Sánchez L; Macia Á; Heras SR; García-Pérez JL; Merino JM; Fernández-Salguero PM
Nucleic Acids Res; 2016 Jun; 44(10):4665-83. PubMed ID: 26883630
[TBL] [Abstract][Full Text] [Related]
3. Binding Mode and Structure-Activity Relationships of ITE as an Aryl Hydrocarbon Receptor (AhR) Agonist.
Dolciami D; Gargaro M; Cerra B; Scalisi G; Bagnoli L; Servillo G; Fazia MAD; Puccetti P; Quintana FJ; Fallarino F; Macchiarulo A
ChemMedChem; 2018 Feb; 13(3):270-279. PubMed ID: 29266750
[TBL] [Abstract][Full Text] [Related]
4. Lidamycin induces neural differentiation of mouse embryonic carcinoma cells through down-regulation of transcription factor Oct4.
Zhen HY; He QH; Li Y; Zhou J; Yao C; Liu YN; Ma LJ
Biochem Biophys Res Commun; 2012 Apr; 421(1):44-50. PubMed ID: 22480685
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of human Oct4 by steroidogenic factor-1.
Yang HM; Do HJ; Kim DK; Park JK; Chang WK; Chung HM; Choi SY; Kim JH
J Cell Biochem; 2007 Aug; 101(5):1198-209. PubMed ID: 17226773
[TBL] [Abstract][Full Text] [Related]
6. Akt‑mediated phosphorylation of Oct4 is associated with the proliferation of stem‑like cancer cells.
Zhao QW; Zhou YW; Li WX; Kang B; Zhang XQ; Yang Y; Cheng J; Yin SY; Tong Y; He JQ; Yao HP; Zheng M; Wang YJ
Oncol Rep; 2015 Apr; 33(4):1621-9. PubMed ID: 25625591
[TBL] [Abstract][Full Text] [Related]
7. An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells.
Novikov O; Wang Z; Stanford EA; Parks AJ; Ramirez-Cardenas A; Landesman E; Laklouk I; Sarita-Reyes C; Gusenleitner D; Li A; Monti S; Manteiga S; Lee K; Sherr DH
Mol Pharmacol; 2016 Nov; 90(5):674-688. PubMed ID: 27573671
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activation of OCT4 by the ETS transcription factor PEA3 in NCCIT human embryonic carcinoma cells.
Park SW; Do HJ; Ha WT; Han MH; Park KH; Song H; Kim NH; Kim JH
FEBS Lett; 2014 Aug; 588(17):3129-36. PubMed ID: 24983502
[TBL] [Abstract][Full Text] [Related]
9. Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells.
Chang CJ; Chien Y; Lu KH; Chang SC; Chou YC; Huang CS; Chang CH; Chen KH; Chang YL; Tseng LM; Song WS; Wang JJ; Lin JK; Huang PI; Lan YT
Biochem Biophys Res Commun; 2011 Nov; 415(2):245-51. PubMed ID: 22037460
[TBL] [Abstract][Full Text] [Related]
10. The aryl hydrocarbon receptor constitutively represses c-myc transcription in human mammary tumor cells.
Yang X; Liu D; Murray TJ; Mitchell GC; Hesterman EV; Karchner SI; Merson RR; Hahn ME; Sherr DH
Oncogene; 2005 Nov; 24(53):7869-81. PubMed ID: 16091746
[TBL] [Abstract][Full Text] [Related]
11. A potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo.
Henry EC; Bemis JC; Henry O; Kende AS; Gasiewicz TA
Arch Biochem Biophys; 2006 Jun; 450(1):67-77. PubMed ID: 16545771
[TBL] [Abstract][Full Text] [Related]
12. SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets.
Murakami S; Ninomiya W; Sakamoto E; Shibata T; Akiyama H; Tashiro F
Stem Cells; 2015 Sep; 33(9):2652-63. PubMed ID: 26013162
[TBL] [Abstract][Full Text] [Related]
13. The aryl hydrocarbon receptor and light.
Rannug A; Fritsche E
Biol Chem; 2006 Sep; 387(9):1149-57. PubMed ID: 16972782
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of OCT4 by the ETS transcription factor ESE-1 in NCCIT human embryonic carcinoma cells.
Park SW; Do HJ; Ha WT; Han MH; Yang HM; Lee SH; Song H; Kim NH; Kim JH
Biochem Biophys Res Commun; 2014 Jul; 450(2):984-90. PubMed ID: 24971534
[TBL] [Abstract][Full Text] [Related]
15. Selective anticancer effects of a synthetic flavagline on human Oct4-expressing cancer stem-like cells via a p38 MAPK-dependent caspase-3-dependent pathway.
Emhemmed F; Ali Azouaou S; Thuaud F; Schini-Kerth V; Désaubry L; Muller CD; Fuhrmann G
Biochem Pharmacol; 2014 May; 89(2):185-96. PubMed ID: 24607276
[TBL] [Abstract][Full Text] [Related]
16. Activation of the Ah receptor by tryptophan and tryptophan metabolites.
Heath-Pagliuso S; Rogers WJ; Tullis K; Seidel SD; Cenijn PH; Brouwer A; Denison MS
Biochemistry; 1998 Aug; 37(33):11508-15. PubMed ID: 9708986
[TBL] [Abstract][Full Text] [Related]
17. Growth and Differentiation Factor 3 Is Transcriptionally Regulated by OCT4 in Human Embryonic Carcinoma Cells.
Han MH; Park SW; Do HJ; Chung HJ; Song H; Kim JH; Kim NH; Park KH; Kim JH
Biol Pharm Bull; 2016; 39(11):1802-1808. PubMed ID: 27803451
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid enhances Oct4 promoter activity in myogenic cells.
Teng HF; Kuo YL; Loo MR; Li CL; Chu TW; Suo H; Liu HS; Lin KH; Chen SL
J Cell Biochem; 2010 Jul; 110(4):995-1004. PubMed ID: 20564199
[TBL] [Abstract][Full Text] [Related]
19. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1.
Zhang J; Tam WL; Tong GQ; Wu Q; Chan HY; Soh BS; Lou Y; Yang J; Ma Y; Chai L; Ng HH; Lufkin T; Robson P; Lim B
Nat Cell Biol; 2006 Oct; 8(10):1114-23. PubMed ID: 16980957
[TBL] [Abstract][Full Text] [Related]
20. Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis.
Hu T; Liu S; Breiter DR; Wang F; Tang Y; Sun S
Cancer Res; 2008 Aug; 68(16):6533-40. PubMed ID: 18701476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
